Mastocytosis Registry of Zurich
Part of Cancer, Immune system & allergy clinical trials.
This study is a registry (a simple data collection) for people with mastocytosis or hypertryptasemia who are treated at the University Hospital of Zurich. It aims to gather information to better understand these conditions and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with mastocytosis or high tryptase levels (hypertryptasemia)
- You are being treated at the University Hospital of Zurich
- You are willing to sign a consent form to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what causes mast cells to grow too much in people with mastocytosis. It may help researchers find better ways to diagnose or treat this condition. You can take part in person or by telehealth.
This study looks at how different types of cells behave in people with mild forms of mastocytosis (a condition with too many mast cells in the skin). Researchers will take skin samples to understand the disease better, which may help develop future treatments.
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
This study builds a “registry,” which is a secure list of people with rare diseases or suspected rare diseases in Switzerland. It helps researchers better understand these conditions over time and improve care.
This study sets up a national registry to collect information about people with neuroendocrine tumors. It helps researchers understand these cancers better and improve care over time.
This trial is a registry that collects health information from people with amyloidosis, including cases where the heart may be involved. Sharing your medical details can help researchers learn how this condition affects patients and may guide future care.
Hear when a new Mastocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.